Division of Rheumatology

Rafat Faraawi

MD, FRCP(C), FACP

Associate Clinical Professor, Division of Rheumatology, Department of Medicine

Rheumatologist

 

 

Education and Professional Standing

  • American Board of Rheumatology, November 1992
  • Fellow, Royal College of Physicians (F.R.C.P.(C)) – Rheumatology, December 1989
  • Fellow, Royal College of Physicians (F.R.C.P.(C)) – Internal Medicine, June 1988
  • American Board of Internal Medicine, September 1987
  • M.B.CH., B., University of Alexandria, Egypt, 1978 - Honours degree
  • Assistant Professor - McMaster University, Hamilton, ON
  • Consultant Rheumatologist - St. Mary’s General Hospital, Kitchener, ON
  • Consultant Rheumatologist - Grand River Hospital, Kitchener, ON
  • Principal Investigator - K-W Musculoskeletal Research Inc.
  • Fellow, Royal College of Physicians of Canada
  • Fellow, American College of Physicians
  • Fellow, American College of Rheumatology
  • Fellow, Canadian Rheumatism Association
  • Member, British Society of Rheumatology
  • Nominated for: Outstanding Teaching Award, University of Manitoba , Winnipeg , Manitoba 1987–1988
  • Principal Investigator involved in over 30 Phase II / III Clinical Research Trials.

Research Interests

  • Rheumatoid Arthritis
  • Osteoarthritis
  • Osteoporosis

Selected Publications

  1. “Treatment of Osteoarthritis and Rheumatoid Arthritis,” The Medical Post, November 2000.
  2. “Septic Arthritis due to Mycobacterium marinum,” The Journal of Rheumatology, 1994 (21:957-60).
  3. “Arthritis in Hemochromatosis,” The American Journal of Rheumatology, March 1993.
  4. “E.Coli Endophthalmitis and Pyelonephritis,” The American Journal of Medicine, March 1987.
  5. “HLAB-27 and Membranous Glomerulonephritis in Rheumatoid Arthritis,” American Rheumatism Association Poster Presentation 1988.
  6. “Retrospective Study in Intra-articular Injection with Hylan G-F 20” for The Canadian Rheumatology Association, Poster Presentation February 2003
  7. “Osteoporosis in Men: A New Type of Patient,” The Canadian Journal of Diagnosis, May 2004
  8. “Gout at a Glance,” The Canadian Journal of Diagnosis, August 2004
  9. “Osteoporosis in Men” (Review Article) Saudi Medical Journal –April 2005.
  10. “Safety and Efficacy of Infliximab in a Community Rheumatology Office – Poster Presentation Eular 2005
  11. Letter to the Author Saudi Medical Journal (Osteoporosis in Men) – September 2005
  12. “New Onset Pustular Psoriasis in Patient with Ankylosing Spondylitis during the Course of Treatment with Infliximab” – Abstract CRA 2007
  13. “Bronchiolitis Obliterans Organizing Pneumonia (BOOP) in a Patient with Rheumatoid Arthritis Treated with Infliximab” – Abstract CRA 2007
  14. "Tocilizumab Monotherapy Improves Quality of Life Compared with Methotrexate Monotherapy in Patients with Rheumatoid Arthritis: The Ambition Study" – Abstract EULAR 2008
  15. "Interim Analysis of the Remitrac Infusion Registry following the Incidence and Management of Infusion Reaction with Infliximab", Canadian Rheumatology Association, March 2008
  16. "Upper Gastrointestinal Tolerability of Alendronate Sodium Monohydrate 10mg Once Daily in Postmenopausal Women: A 12-week, Randomized, Double-Blind, Placebo-Controlled, Exploratory Study", Clinical Therapeutics/Volume 31, August 2009